|
RABGAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.40329999995548E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.11900000000043E-05 |
| Normal-vs-Stage2 |
5.658900E-03 |
| Normal-vs-Stage3 |
2.38759999993121E-07 |
| Normal-vs-Stage4 |
5.223100E-04 |
| Stage1-vs-Stage2 |
5.823200E-01 |
| Stage1-vs-Stage3 |
4.644300E-02 |
| Stage1-vs-Stage4 |
4.834400E-01 |
| Stage2-vs-Stage3 |
4.146400E-02 |
| Stage2-vs-Stage4 |
2.407400E-01 |
| Stage3-vs-Stage4 |
7.237000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.16390000002043E-06 |
| Normal-vs-AfricanAmerican |
1.781580E-03 |
| Normal-vs-Asian |
1.136810E-03 |
| Caucasian-vs-AfricanAmerican |
4.594400E-01 |
| Caucasian-vs-Asian |
4.796000E-01 |
| AfricanAmerican-vs-Asian |
2.600400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.12880000019611E-07 |
| Normal-vs-Female |
7.064100E-02 |
| Male-vs-Female |
5.440100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.342600E-03 |
| Normal-vs-Extreme_Weight |
4.76510000002595E-06 |
| Normal-vs-Obese |
5.017600E-03 |
| Normal-vs-Extreme_Obese |
2.439900E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.661200E-01 |
| Normal_Weight-vs-Obese |
4.613800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.457600E-01 |
| Extreme_Weight-vs-Obese |
1.944610E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.576600E-01 |
| Obese-vs-Extreme_Obese |
4.768400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.097600E-03 |
| Normal-vs-Age(41-60Yrs) |
2.060200E-02 |
| Normal-vs-Age(61-80Yrs) |
6.34910000130162E-08 |
| Normal-vs-Age(81-100Yrs) |
2.45649999999209E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.419400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.561800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.928000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.076700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.150500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.099400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.035400E-03 |
| Normal-VS-Type2 PRCC |
1.42389999790993E-08 |
| Normal-VS-KIRP CIMP |
8.837800E-02 |
| Normal-VS-Unclassified PRCC |
6.586900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.88889999999509E-05 |
| Type1 PRCC-VS-KIRP CIMP |
5.887600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.787040E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.259000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.494170E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.181000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.1757000362731E-09 |
| Normal-vs-N1 |
1.646070E-02 |
| Normal-vs-N2 |
1.501850E-02 |
| N0-vs-N1 |
2.531400E-01 |
| N0-vs-N2 |
7.061200E-01 |
| N1-vs-N2 |
7.831600E-01 |
|
|
